PAHCPHIBRO ANIMAL HEALTH CORP

Nasdaq pahc.com


$ 21.96 $ 0.78 (3.68 %)    

Friday, 13-Sep-2024 15:59:59 EDT
QQQ $ 474.86 $ 2.12 (0.45 %)
DIA $ 414.87 $ 2.97 (0.72 %)
SPY $ 561.82 $ 2.92 (0.52 %)
TLT $ 100.40 $ 0.27 (0.27 %)
GLD $ 238.66 $ 2.35 (0.99 %)
$ 21.99
$ 21.23
$ 21.96 x 198
-- x --
$ 21.14 - $ 22.06
$ 9.09 - $ 22.17
169,498
na
890.67M
$ 0.88
$ 368.66
TBD
na
na ($ 0.02)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-28-2024 06-30-2024 10-K
2 05-08-2024 03-31-2024 10-Q
3 02-07-2024 12-31-2023 10-Q
4 11-08-2023 09-30-2023 10-Q
5 08-30-2023 06-30-2023 10-K
6 05-03-2023 03-31-2023 10-Q
7 02-08-2023 12-31-2022 10-Q
8 11-09-2022 09-30-2022 10-Q
9 08-24-2022 06-30-2022 10-K
10 05-04-2022 03-31-2022 10-Q
11 02-09-2022 12-31-2021 10-Q
12 11-02-2021 09-30-2021 10-Q
13 08-25-2021 06-30-2021 10-K
14 05-06-2021 03-31-2021 10-Q
15 02-03-2021 12-31-2020 10-Q
16 11-04-2020 09-30-2020 10-Q
17 08-26-2020 06-30-2020 10-K
18 05-07-2020 03-31-2020 10-Q
19 02-03-2020 12-31-2019 10-Q
20 11-04-2019 09-30-2019 10-Q
21 08-27-2019 06-30-2019 10-K
22 05-06-2019 03-31-2019 10-Q
23 02-06-2019 12-31-2018 10-Q
24 11-06-2018 09-30-2018 10-Q
25 08-27-2018 06-30-2018 10-K
26 05-07-2018 03-31-2018 10-Q
27 02-05-2018 12-31-2017 10-Q
28 11-06-2017 09-30-2017 10-Q
29 08-30-2017 06-30-2017 10-K
30 05-08-2017 03-31-2017 10-Q
31 02-06-2017 12-31-2016 10-Q
32 11-09-2016 09-30-2016 10-Q
33 08-29-2016 06-30-2016 10-K
34 05-09-2016 03-31-2016 10-Q
35 02-09-2016 12-31-2015 10-Q
36 11-09-2015 09-30-2015 10-Q
37 09-10-2015 06-30-2015 10-K
38 05-11-2015 03-31-2015 10-Q
39 02-10-2015 12-31-2014 10-Q
40 11-12-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 jp-morgan-initiates-coverage-on-phibro-animal-health-with-neutral-rating-announces-price-target-of-22

JP Morgan analyst Ekaterina Knyazkova initiates coverage on Phibro Animal Health (NASDAQ:PAHC) with a Neutral rating and ann...

 b-of-a-securities-maintains-underperform-on-phibro-animal-health-raises-price-target-to-15

B of A Securities analyst Derik De Bruin maintains Phibro Animal Health (NASDAQ:PAHC) with a Underperform and raises the pri...

 phibro-animal-health-expects-fy25-net-sales-of-104b---109b-est-113b

Adjusted EBITDA of $118 million to $126 million

 phibro-animal-health-q4-2024-adj-eps-041-beats-033-estimate-sales-273200m-beat-263245m-estimate

Phibro Animal Health (NASDAQ:PAHC) reported quarterly earnings of $0.41 per share which beat the analyst consensus estimate of ...

 barclays-maintains-underweight-on-phibro-animal-health-raises-price-target-to-13

Barclays analyst Balaji Prasad maintains Phibro Animal Health (NASDAQ:PAHC) with a Underweight and raises the price target f...

 phibro-animal-health-q3-2024-adj-eps-031-beats-029-estimate-sales-263200m-beat-254825m-estimate

Phibro Animal Health (NASDAQ:PAHC) reported quarterly earnings of $0.31 per share which beat the analyst consensus estimate of ...

Core News & Articles

Zoetis Inc. (NYSE:ZTS) and Phibro Animal Health Corporation (NASDAQ:PAHC) today announced that they have entered into a definit...

 phibro-animal-health-affirms-2024-adj-eps-and-net-sales-guidance

We affirm our previously issued fiscal year 2024 guidance for the following measures:Net sales of $980 million to $1.020 billio...

 phibro-animal-health-q2-2024-adj-eps-033-beats-028-estimate-sales-24990m-beat-24230m-estimate

Phibro Animal Health (NASDAQ:PAHC) reported quarterly earnings of $0.33 per share which beat the analyst consensus estimate of ...

 earnings-scheduled-for-february-7-2024

Companies Reporting Before The Bell • Madison Square Garden (NYSE:MSGE) is expected to report quarterly loss at $0.80 per shar...

 phibro-animal-health-corporation-announces-glenn-c-david-has-joined-phibro-and-will-assume-the-role-of-chief-financial-officer-effective-february-9-2024

Phibro Animal Health Corporation (NASDAQ:PAHC) (the "Company" or "Phibro") today announced that Glenn C. David ...

 why-amc-entertainment-shares-are-trading-lower-by-around-14-here-are-other-stocks-moving-in-thursdays-mid-day-session

Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 83.5% to $0.4169 after reporting first-quarter results.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION